Concepedia

Jamal Misleh

JM

Statistics

Publications

10

Citations

531

H-Index

10

Active since

2014

Affiliations

Medical Oncology Hematology Consultants(Current)

Christiana Care Health System

Florida Cancer Specialists & Research Institute

Tennessee Oncology

Indiana University Health

Jamal Misleh is an author at Medical Oncology Hematology Consultants specializing in cancer therapeutics, pharmacotherapy, and drug discovery.

ORCID

Top concepts

Publications per year

2014–2023

10

Publications

10

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Jhanelle E. Gray, Rebecca S. Heist, Alexander Starodub et al. · Clinical Cancer Research · 2017 · 155 citations · Full text

Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study

Mazyar Shadman, Ian W. Flinn, Moshe Levy et al. · The Lancet Haematology · 2022 · 81 citations

, , +9

Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study

Song Yao, Qiang Hu, Sarah L. Kerns et al. · Clinical Epigenetics · 2019 · 64 citations · Full text

Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer

Allison Magnuson, Lianlian Lei, Nikesha Gilmore et al. · Journal of the American Geriatrics Society · 2019 · 58 citations · Full text

Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance)

Jonathan E. Rosenberg, Karla V. Ballman, Susan Halabi et al. · Journal of Clinical Oncology · 2021 · 55 citations · Full text

1–5 of 10